Chronic obstructive pulmonary disease (COPD) and respiratory tract infections represent significant contributors to mortality and morbidity on a global scale. COPD is defined as a chronic inflammatory condition affecting the airways and lung parenchyma, predominantly induced by smoking. It is characterized by symptoms such as persistent cough, dyspnea, and increased sputum production1. The World Health Organization projects that by 2030, COPD will rank as the third leading cause of death worldwide, imposing a substantial economic burden2,3. In contrast, respiratory tract infections (RTI) account for approximately 6% of the global disease burden, surpassing the burden associated with ischemic heart disease, HIV infection, cancer, malaria, and diarrheal diseases4.
Due to the substantial similarities in the clinical manifestations of the two diseases, particularly in the symptomatology of cough, which is a prevalent symptom, early and precise differentiation between these diseases is essential for effective treatment5,6. Traditional diagnostic approaches predominantly depend on clinical symptom assessment, lung function testing, and laboratory analyses7. While conventional diagnostic methods for COPD are effective in identifying and evaluating the condition, they exhibit several limitations in clinical practice. These limitations include inadequate diagnostic accuracy, limited capacity for early diagnosis, insufficient understanding of disease heterogeneity, and a lack of dynamic monitoring8,9,10,11. In contrast to traditional diagnostic methods for COPD, voice diagnosis technology, as an emerging auxiliary tool, offers numerous advantages, particularly in early detection, non-invasive diagnosis, and dynamic monitoring.
With advancements in speech analysis, particularly the automated analysis of cough sounds, there is emerging potential for rapid diagnostic applications. Research indicates that cough sounds encapsulate extensive information regarding pulmonary diseases, with their acoustic features reflecting alterations in airway health status12. Recently, machine learning-based techniques for speech feature analysis have been employed in diagnosing COPD and other conditions, yielding notable outcomes13,14,15. These methodologies facilitate the effective classification of diseases by extracting audio features from cough sounds, such as frequency, duration, and amplitude, and integrating them with machine learning algorithms for pattern recognition.
Despite some studies investigating the potential of cough sound analysis in disease diagnosis, significant challenges persist in differentiating between COPD patients and those with RTI. This difficulty arises due to overlapping characteristics in the cough sounds of both groups, compounded by individual variability. Consequently, the development of methods to extract more precise and distinguishable features from cough sounds remains a critical issue in this domain.
This study seeks to investigate an automated classification method for cough sounds by recording audio from 25 patients diagnosed with COPD and 25 patients with RTI. By integrating speech feature analysis with machine learning algorithms, we aim to enhance the accuracy of disease differentiation, thereby improving early diagnostic capabilities for COPD and RTI.